Literature DB >> 2765368

Colony forming ability of human breast carcinomas: lack of prognostic significance.

L Ottestad1, K M Tveit, E Hannisdal, M Skrede, J M Nesland, S Gundersen, A Pihl.   

Abstract

To study whether colony growth in vitro reflects the prognosis of breast cancer patients, specimens from a total number of 138 patients with primary breast carcinomas were cultivated in the Courtenay-Mills soft agar method. The plating efficiency (PE) values were related to various clinical and histopathological parameters. No significant correlation was found between colony forming ability and menopausal status, histopathology, TNM-status or steroid hormone receptor status. The crude survival of the patients was not significantly correlated to the in vitro growth of the tumours; neither was there any difference in relapse-free survival between patients whose tumours failed to grow in vitro and those having growing tumours (PE greater than 0). A multivariate survival analysis of 115 patients with primary tumours without distant metastases revealed that the PE was not a significant independent prognostic indicator, as it gave no additional prognostic information above that of node and ER status. It is concluded that routine measurement of colony formation in vitro is not warranted in the management of breast cancer.

Entities:  

Mesh:

Year:  1989        PMID: 2765368      PMCID: PMC2247049          DOI: 10.1038/bjc.1989.254

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.

Authors:  L G Dressler; L C Seamer; M A Owens; G M Clark; W L McGuire
Journal:  Cancer       Date:  1988-02-01       Impact factor: 6.860

2.  Surviving proportional hazards.

Authors:  J D Elashoff
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

3.  The human tumor stem cell assay revisited.

Authors:  S E Singletary; G E Umbach; G Spitzer; B Drewinko; B Tomasovic; J Ajani; V Hug; G Blumenschein
Journal:  Int J Cell Cloning       Date:  1985-03

Review 4.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

5.  Breast cancer as analyzed by the human tumor stem cell assay.

Authors:  C M Sutherland; F J Mather; R D Carter; E J Cerise; E T Krementz
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

6.  Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.

Authors:  O P Kallioniemi; G Blanco; M Alavaikko; T Hietanen; J Mattila; K Lauslahti; M Lehtinen; T Koivula
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  In vitro sensitivity of human melanoma xenografts to cytotoxic drugs. Correlation with in vivo chemosensitivity.

Authors:  K M Tveit; O Fodstad; S Olsnes; A Pihl
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

8.  Cell kinetics as a prognostic marker in node-negative breast cancer.

Authors:  R Silvestrini; M G Daidone; G Gasparini
Journal:  Cancer       Date:  1985-10-15       Impact factor: 6.860

9.  The human tumour cloning assay in the management of breast cancer patients.

Authors:  C Dittrich; R Jakesz; F Wrba; L Havelec; O Haas; J Spona; H Holzner; R Kolb; K Moser
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

10.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.

Authors:  V D Courtenay; J Mills
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  1 in total

1.  Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.

Authors:  D J DeFriend; E Anderson; J Bell; D P Wilks; C M West; R E Mansel; A Howell
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.